Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium

Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes

(2012) M. E. Hellemons et al.   DIABETES CARE

Impaired Vasodilation in the Pathogenesis of Hypertension: Focus on Nitric Oxide, Endothelial-Derived Hyperpolarizing Factors, and Prostaglandins

(2012) Thomas D. Giles et al.   Journal of Clinical Hypertension

Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice

(2012) Huifang Cheng et al.   KIDNEY INTERNATIONAL

Caveolae, caveolin, and cavins: Potential targets for the treatment of cardiac disease

(2011) Manika Das et al.   ANNALS OF MEDICINE

Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside

(2011) Xinye Xu et al.   BIOMARKERS

A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice

(2011) Pascal Bernatchez et al.   JOURNAL OF CLINICAL INVESTIGATION

Losartan protects mesenteric arteries from ROS-associated decrease in myogenic constriction following 5/6 nephrectomy

(2011) Peter Vavrinec et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

(2011) Tibor Kempf et al.   NATURE MEDICINE

Elevated systemic TGF-β impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE−/− mice

(2010) Anna Buday et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation

(2010) Eiichiro Yamamoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy

(2010) M. Lajer et al.   DIABETES CARE

Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study

(2010) Maren Carstensen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Adjunct Nitrous Oxide Normalizes Vascular Reactivity Changes after Hemorrhagic Shock in Mice under Isoflurane Anesthesia

(2009) Iryna V. Samarska et al.   ANESTHESIOLOGY

Possible new druggable targets for the treatment of nephrosis

(2009) Richard PE van Dokkum et al.   CURRENT OPINION IN PHARMACOLOGY

The regulation of TGF  signal transduction

(2009) A. Moustakas et al.   DEVELOPMENT

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction

(2009) S. Q. Khan et al.   EUROPEAN HEART JOURNAL

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

(2009) L. Lind et al.   EUROPEAN HEART JOURNAL

Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet

(2009) Ivana Dostálová et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Caveolae and endothelial dysfunction: Filling the caves in cardiovascular disease

(2008) Ying Xu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Systemic gene therapy with interleukin-13 attenuates renal ischemia–reperfusion injury

(2008) M. Sandovici et al.   KIDNEY INTERNATIONAL